Alkermes plc - Ordinary Shares (ALKS): Price and Financial Metrics
Alkermes plc - Ordinary Shares (ALKS)
Today's Latest Price: $22.85 USD
Updated Jan 19 4:00pm
Add ALKS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ALKS Stock Summary
- ALKS's went public 29.53 years ago, making it older than 83.32% of listed US stocks we're tracking.
- The price/operating cash flow metric for Alkermes plc is higher than 92.36% of stocks in our set with a positive cash flow.
- With a year-over-year growth in debt of 31.62%, Alkermes plc's debt growth rate surpasses 76.43% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Alkermes plc, a group of peers worth examining would be EMKR, PSNL, RIGL, BBI, and ATNX.
- ALKS's SEC filings can be seen here. And to visit Alkermes plc's official web site, go to www.alkermes.com.
ALKS Stock Price Chart Interactive Chart >
ALKS Price/Volume Stats
| Current price | $22.85 | 52-week high | $23.02 |
| Prev. close | $22.37 | 52-week low | $11.98 |
| Day low | $22.30 | Volume | 1,335,426 |
| Day high | $23.02 | Avg. volume | 1,504,542 |
| 50-day MA | $19.76 | Dividend yield | N/A |
| 200-day MA | $17.78 | Market Cap | 3.64B |
Alkermes plc - Ordinary Shares (ALKS) Company Bio
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 and is based in Dublin, Ireland.
Loading social stream, please wait...